After the Korean registration, Coreleader is proud to announce that it has received the very first product approval form the CFDA, mainalnd CHina regulatory agency, after the effort for last four years. The product registration is for Algi-white, a non-woven alginate wound dressing, covering the wound healing and hemostasis after the hemodialysis. 

Coreleader is planning to recruit at least 8 to 10 dealers for the market development in mainland China. Each one of them would cover several provinces but not an exclusive country dealer for China. The first interview is planned at Shang Hai in end July followed by the interview in Kuang-zhou for those dealers located in southern China. Interested should file the application and join the interview with their marketing mix strategy. A trip to central mainland China would be arranged in August. Will soon be announced.